Dose Modification of Subcutaneous Tocilizumab in Patients with Rheumatoid Arthritis
Am Health Drug Benefits
.
2020 May;13(2):72-73.
Authors
Jennie H Best
1
,
Ibrahim Abbass
1
,
Lenore Tominna
1
,
William Reiss
1
Affiliation
1
Genentech, Inc., South San Francisco, CA.
PMID:
32724501
PMCID:
PMC7370831
No abstract available